|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2025
vol. 127 Review article
Mucopolysaccharidosis in children as seen through the eyes of an ophthalmologist
Mirosława Grałek
1
,
Anna Niwald
1
,
Katarzyna Piasecka
1
KLINIKA OCZNA 2025, 127, 1: 1-5
Online publish date: 2024/07/09
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
1. Khan SA, Peracha H, Ballhausen D i wsp. Epidemiology of mucopolysaccharidoses. Mol Genet Metab 2017; 121: 227-240. 2.
Iozzo RV, Schaefer L. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol 2015; 42: 11-55. 3.
Wiśniewska K, Wolski J, Gaffke L i wsp. Misdiagnosis in mucopolysaccharidoses. J Appl Genet 2022; 63: 475-495. 4.
Lin HY, Lin SP, Chuang CK i wsp. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004. Am J Med Genet Am 2009; 149A: 960-964. 5.
Jurecka A, Ługowska A, Golda A i wsp. Prevalence rates of mucopolysaccharidoses in Poland. J Appl Genet 2015; 56: 205-210. 6.
Nagpal R, Goyal RB, Priyadarshini K i wsp. Mucopolysaccharidosis: A broad review. Indian J Ophthalmol 2022; 70: 2249-2261. 7.
Lin HY, Chan WC, Chen LJ i wsp. Ophthalmologic manifestations in Taiwanese patients with mucopolysaccharydoses. Mol Genet Genomic Med 2019; 7: e00617. 8.
Giugliani R, Harmatz P, Lin SP, Scarpa M. Assessing the impact of the five senses on quality of life in mucopolysaccharidoses. Orphanet J Rare Dis 2020; 15: 97. 9.
Tomatsu S, Pitz S, Hampel U. Ophthalmological findings in mucopolysaccharidoses. J Clin Med 2019; 8: 1467. 10.
Ashworth JL, Biswas S, Wraith E, Lloyd IC. Mucopolysaccharidoses and the eye. Surv Ophthalmol 2006; 51: 1-17. 11.
Ashworth JL, Kruse FE, Bachmann B i wsp. Ocular manifestations in the mucopolysaccharidoses – a review. Clin Experiment Ophthalmol 2010; 38: 12-22. 12.
Ferrai S, Ponzin D, Ashworth JL i wsp. Diagnosis and management of ophthalmological features in patients with mucopolysaccharydosis. Br J Ophtghalmol 2011; 95: 613-619. 13.
Villas-Bôas FS, Filho DJF, Acosta AX. Ocular findings in patients with muccopolysaccharidosis. Arq Bras Oftalmol 2011; 74: 430-434. 14.
Modrzejewska M, Kotl A, Wiśniewska A, Giżewska M. Mukopolisacharydoza a narząd wzroku. Klin Oczna 2013; 115: 152-157. 15.
Fenzl CR, Teramoto K, Moshirfar M. Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses. Clin Ophthalmol 2015; 7: 1633-1644. 16.
Javed A, Aslam T, Jones SA, Ashworth J. Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis. Invest Ophthalmol Vis Sci 2017; 58: 954-958. 17.
Kong W, Zhang J, Lu C, Ding Y, Meng Y. Glaucoma in mucopolysaccharidoses. Orphanet J Rare Dis 2021; 16: 312. 18.
Summers CG, Ashworth JL. Ocular manifestations as key features for diagnosing mucopolysaccharidoses. Rheumatology (Oxford) 2011; 50 Suppl 5: v34-40. 19.
Ashworth J, Flaherty M, Pitz S, Ramlee A. Assessment and diagnosis of suspected glaucoma in patients with mucopolysaccharidosis. Acta Ophthalmol 2015; 93: e111-117. 20.
Del Longo A, Piozzi E, Schweizer F. Ocular features in mucopolysaccharidosis: diagnosis and treatment. Ital J Pediatr 2018; 44 (Suppl 2): 125. 21.
Prusek K, Kucharz E. Enzymatyczna terapia zastępcza w leczeniu mukopolisacharydoz. Reumatologia 2011; 49: 122-125. 22.
Ohden KL, Pitz S, Ashworth J i wsp. Outcomes of keratoplasty in the mucopolysaccharidoses: an international perspective. Br J Ophthalmol 2017; 101: 909-912. 23.
Hallal R Jr, Armstrong GW, Pineda R. Long-Term Outcomes of Big Bubble Deep Anterior Lamellar Keratoplasty in Mucopolysaccharidoses: A Retrospective Case Series and Review of the Literature. Cornea 2022; 41: 809-814.
|
POLSKI
